Assessment of the Influence of Inflammation and FCGR3A Genotype on Infliximab Pharmacokinetics and Time to Relapse in Patients with Crohn’s Disease
Crossref DOI link: https://doi.org/10.1007/s40262-014-0225-3
Published Online: 2014-12-17
Published Print: 2015-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ternant, David
Berkane, Zahir
Picon, Laurence
Gouilleux-Gruart, Valérie
Colombel, Jean-Frédéric
Allez, Matthieu
Louis, Edouard
Paintaud, Gilles
Text and Data Mining valid from 2014-12-17